Supelanas, Merry Jean .

HRN: 28-87-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2026
06/08/2026
IV
500
Q8 X 3 Doses
Sp Ltcs
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines